Rare diseases
Investigational molecules
Locations
Viale Camillo Golgi 19, 27100 Pavia, Italy
Research activity includes the prevention and monitoring of cardiac toxicity associated with cancer treatment, with particular interest in patients with breast cancer receiving therapies that may affect left ventricular function and broader cardiovascular safety.
The clinical focus extends to identifying strategies that reduce treatment-related myocardial injury and preserve cardiac performance during oncologic therapy.
Fondazione IRCCS Policlinico San Matteo runs clinical trials in conditions such as Arrhythmic storm, Chronic obstructive pulmonary disease, Chemotherapy cardiotoxicity attenuation, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyItalyItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
